Mounjaro vs. Adipex

See how Mounjaro and Adipex compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Mounjaro is an injectable dual GIP/GLP-1 agonist approved for type 2 diabetes, while Adipex is an oral stimulant approved only for short-term weight loss.

  • Mounjaro follows a 21-week dose titration schedule, while Adipex is prescribed at a fixed dose from the first day of treatment.

  • Adipex is a Schedule IV controlled substance with abuse potential, while Mounjaro carries a boxed warning for thyroid C-cell tumors seen in animal studies.

Mounjaro vs. Adipex Drug Summary

Mounjaro

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist FDA-approved to control blood sugar in adults and children 10 and older with type 2 diabetes. It is given as a once-weekly subcutaneous injection with a dose that increases every four weeks. It is also used off-label for weight loss in people without diabetes.

Adipex

Adipex (phentermine) is a sympathomimetic stimulant FDA-approved as a short-term adjunct to diet and exercise for weight loss in obesity. It is taken orally, usually once daily, and is not intended for long-term use. It has been prescribed since 1959 and remains one of the most widely used weight-loss medications in the U.S.

Mounjaro vs. Adipex Side Effects

Mounjaro

Most common
nausea (12-18%)
diarrhea (12-17%)
decreased appetite (8-11%)
vomiting (5-9%)

Adipex

Most common
insomnia (not specified)
dizziness (not specified)
restlessness (not specified)
dry mouth (not specified)

Mounjaro vs. Adipex Dosage

Mounjaro

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 2.5 mg once weekly Weeks 1-4
Maximum dose 15 mg once weekly Week 21 onward
Dose changes 5 increases Every 4 weeks

Adipex

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 15 mg once daily At the start
Maximum dose 15 mg once daily Same as starting
Dose changes None Fixed dose

Mounjaro vs. Adipex Indications

Mounjaro

Mounjaro is FDA-approved to improve blood sugar control in adults and in children 10 and older with type 2 diabetes, used alongside diet and exercise. It is not approved for type 1 diabetes. Many prescribers also use it off-label for weight loss in patients without diabetes.

  • Type 2 diabetes blood sugar control in adults

  • Type 2 diabetes blood sugar control in children 10+

  • Off-label: weight loss in people without diabetes

Adipex

Adipex is FDA-approved only as a short-term adjunct to diet and exercise for weight loss in people with obesity. It is not approved for long-term or chronic weight management. It is also not approved for use in patients 16 and younger.

  • Short-term adjunct to diet and exercise for obesity

  • Not approved for long-term weight management

  • Not approved for patients 16 and younger

Mounjaro vs. Adipex Pros and Cons

Mounjaro

Mounjaro offers strong blood sugar control plus significant weight loss in clinical trials, with the convenience of a once-weekly injection. It is a newer, brand-name biologic, so it typically costs more and is not always covered by insurance for off-label weight loss use.

Pros

  • FDA-approved specifically for type 2 diabetes management

  • Only needs to be injected once a week

  • Substantial weight loss demonstrated in clinical trials

  • No known abuse or dependence potential

Cons

  • Roughly $1,000 to $1,300 per month without insurance

  • Requires a subcutaneous injection rather than a pill

  • Boxed warning for thyroid C-cell tumor risk

  • GI side effects like nausea and diarrhea are common

Adipex

Adipex is an inexpensive, well-established oral option for short-term weight loss support. Because it is a stimulant and a controlled substance, it carries cardiovascular and dependence risks that limit it to brief use.

Pros

  • Roughly $50 to $150 per month, far cheaper than Mounjaro

  • Taken as a pill, no injections needed

  • Decades of clinical use and prescribing experience

  • Once-daily oral dosing fits easily into routines

Cons

  • Only approved for a few weeks of use, not long-term

  • Schedule IV controlled substance with abuse potential

  • Contraindicated with heart disease or uncontrolled hypertension

  • Cannot be combined with MAOIs due to hypertensive crisis risk

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.